{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:51:43Z","timestamp":1779277903684,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.humpath.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T10:29:57Z","timestamp":1627122597000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia"],"prefix":"10.1016","volume":"117","author":[{"given":"Anne","family":"Offermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Joerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie C.","family":"Hupe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marten","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Br\u00e4gelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Kirfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel S.","family":"Merseburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Tharun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Perner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.07.006_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2005.03.015","article-title":"Prostatic intraepithelial neoplasia (PIN): importance and clinical management","volume":"48","author":"Joniau","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.07.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.07.006_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2559.2011.04007.x","article-title":"Precursors of prostate cancer","volume":"60","author":"Bostwick","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.07.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2004.10.010","article-title":"High-grade prostatic\u00a0intraepithelial neoplasia in needle biopsy as risk factor for\u00a0detection of adenocarcinoma: current level of risk in screening population","volume":"65","author":"Gokden","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2021.07.006_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2017.138","article-title":"High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate","volume":"31","author":"Zhou","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2010.09.035","article-title":"Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer","volume":"46","author":"Laurila","year":"2010","journal-title":"Eur J Canc"},{"key":"10.1016\/j.humpath.2021.07.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(05)00064-9","article-title":"Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled","volume":"175","author":"Herawi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2021.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/01.pas.0000213324.97294.54","article-title":"Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma","author":"Netto","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.3800053","article-title":"High-grade prostatic intraepithelial neoplasia","volume":"17","author":"Bostwick","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.3800522","article-title":"Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists","volume":"19","author":"Egevad","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X19898472","article-title":"Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia in a tertiary hospital in Northern Jordan","volume":"13","author":"Aldaoud","year":"2020","journal-title":"Clin Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib12","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-16-0094","article-title":"Pan-cancer analysis of the mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer","volume":"23","author":"Br\u00e4gelmann","year":"2017","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2021.07.006_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2901","article-title":"The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation","volume":"11","author":"Malik","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.humpath.2021.07.006_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/nature07179","article-title":"CDK8 is a colorectal cancer oncogene that regulates \u03b2-catenin activity","volume":"455","author":"Firestein","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.07.006_bib15","article-title":"Skp2\u2013MacroH2A1\u2013CDK8 axis orchestrates G2\/M transition and tumorigenesis","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.07.006_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/nature09590","article-title":"The histone variant macroH2A suppresses melanoma progression through regulation of CDK8","volume":"468","author":"Kapoor","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.07.006_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00626-16","article-title":"A kinase-independent role for cyclin-dependent kinase 19 in p53 response","volume":"37","author":"Audetat","year":"2017","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2021.07.006_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-018-0316-y","article-title":"Mediator kinase CDK8\/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer","volume":"37","author":"Serrao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2021.07.006_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1710467114","article-title":"CDK8\/19 Mediator kinases potentiate induction of transcription by NF\u03baB","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2021.07.006_bib20","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.14894","article-title":"Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer","volume":"8","author":"McDermott","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2021.07.006_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/nature14904","article-title":"Mediator kinase inhibition further activates super-enhancer-associated genes in AML","volume":"526","author":"Pelish","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2021.07.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2016.03.030","article-title":"Identification of mediator kinase substrates in human cells using cortistatin A and quantitative phosphoproteomics","volume":"15","author":"Poss","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2021.07.006_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.32551","article-title":"Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer","volume":"146","author":"Becker","year":"2020","journal-title":"Int J Canc"},{"key":"10.1016\/j.humpath.2021.07.006_bib24","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24414","article-title":"CDK8\/19 inhibition induces premature G1\/S transition and ATR-dependent cell death in prostate cancer cells","volume":"9","author":"Nakamura","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2021.07.006_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/01.pas.0000213424.38503.aa","article-title":"TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion","volume":"31","author":"Perner","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2015.10.031","article-title":"Genetic progression of high grade prostatic intraepithelial neoplasia to prostate cancer","volume":"69","author":"Jung","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.07.006_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2004.03.019","article-title":"Analysis of \u03b1-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia","volume":"35","author":"Wu","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/pros.20196","article-title":"Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer","volume":"63","author":"Ananthanarayanan","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2021.07.006_bib29","article-title":"Comparison of annexin II, p63 and -methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study","volume":"60","author":"Stewart","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2015.11.020","article-title":"Shifting paradigms for high-grade prostatic intraepithelial neoplasia","volume":"69","author":"Haffner","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.07.006_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/00000478-200108000-00014","article-title":"Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy","volume":"25","author":"Kronz","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.006_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/pcan.2011.3","article-title":"Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients","volume":"14","author":"Antonelli","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2021.07.006_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30738-7","article-title":"Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study","volume":"21","author":"Str\u00f6m","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:58Z","timestamp":1758645538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":33,"alternative-id":["S0046817721001283"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.07.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}